Australien - engelsk - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - posaconazole, quantity: 40 mg/ml - oral liquid, suspension - excipient ingredients: sodium benzoate; sodium citrate dihydrate; citric acid monohydrate; titanium dioxide; glycerol; xanthan gum; liquid glucose; peg-40 hydrogenated castor oil; purified water; peg-40 stearate; benzoic acid; glyceryl monostearate; methylcellulose; polysorbate 65; simethicone; sorbic acid; sulfuric acid; flavour - posaconazole is indicated for use in the treatment of the following invasive fungal infections in patients 13 years of age or older: ? invasive aspergillosis in patients intolerant of, or with disease that is refractory to, alternative therapy. ? fusariosis, zygomycosis, coccidioidomycosis, chromoblastomycosis, and mycetoma in patients intolerant of, or with disease that is refractory to, alternative therapy.,posaconazole is also indicated for the: ? treatment of oropharyngeal candidiasis in immunocompromised adults, including patients with disease that is refractory to itraconazole and fluconazole. ? prophylaxis of invasive fungal infections among patients 13 years of age and older, who are at high risk of developing these infections, such as patients with prolonged neutropenia or haematopoietic stem cell transplant (hsct) recipients.

Singapore - engelsk - HSA (Health Sciences Authority)

novartis (singapore) pte ltd - brinzolamide; timolol maleate 6.8mg/ml eqv timolol (as free base) - suspension, sterile - 10mg/ml - brinzolamide 10mg/ml; timolol maleate 6.8mg/ml eqv timolol (as free base) 5mg/ml

USA - engelsk - NLM (National Library of Medicine)

novartis ophthalmics - levocabastine hydrochloride (unii: 124xma6yei) (levocabastine - unii:h68bp06s81) - suspension - 0.5 mg in 1 ml - livostin™ 0.05% (levocabastine hydrochloride ophthalmic suspension) is indicated for the temporary relief of the signs and symptoms of seasonal allergic conjunctivitis. this product is contraindicated in persons with known or suspected hypersensitivity to any of its components. it should not be used while soft contact lenses are being worn.

Canada - engelsk - Health Canada

novartis pharmaceuticals canada inc - brinzolamide; brimonidine tartrate - suspension - 1%; 0.2% - brinzolamide 1%; brimonidine tartrate 0.2% - alpha-adrenergic agonists

USA - engelsk - NLM (National Library of Medicine)

alembic pharmaceuticals inc. - brimonidine tartrate (unii: 4s9cl2dy2h) (brimonidine - unii:e6gnx3hhte) - brimonidine tartrate ophthalmic solution, 0.15% is an alpha adrenergic receptor agonist indicated for the reduction of elevated intraocular pressure (iop) in patients with open-angle glaucoma or ocular hypertension. brimonidine tartrate ophthalmic solution is contraindicated in neonates and infants (under the age of 2 years). brimonidine tartrate ophthalmic solution is contraindicated in patients who have exhibited a hypersensitivity reaction to any component of this medication in the past. pregnancy category b: teratogenicity studies have been performed in animals. brimonidine tartrate was not teratogenic when given orally during gestation days 6 through 15 in rats and days 6 through 18 in rabbits. the highest doses of brimonidine tartrate in rats (2.5 mg/kg/day) and rabbits (5.0 mg/kg/day) achieved auc exposure values 360- and 20-fold higher, or 260- and 15-fold higher, respectively, than similar values estimated in humans treated with brimonidine tartrate ophthalmic solution 0.15%,1 drop in both eyes three

USA - engelsk - NLM (National Library of Medicine)

alembic pharmaceuticals limited - brimonidine tartrate (unii: 4s9cl2dy2h) (brimonidine - unii:e6gnx3hhte) - brimonidine tartrate ophthalmic solution, 0.15% is an alpha adrenergic receptor agonist indicated for the reduction of elevated intraocular pressure (iop) in patients with open-angle glaucoma or ocular hypertension. brimonidine tartrate ophthalmic solution is contraindicated in neonates and infants (under the age of 2 years). brimonidine tartrate ophthalmic solution is contraindicated in patients who have exhibited a hypersensitivity reaction to any component of this medication in the past. pregnancy category b: teratogenicity studies have been performed in animals. brimonidine tartrate was not teratogenic when given orally during gestation days 6 through 15 in rats and days 6 through 18 in rabbits. the highest doses of brimonidine tartrate in rats (2.5 mg/kg/day) and rabbits (5.0 mg/kg/day) achieved auc exposure values 360- and 20-fold higher, or 260- and 15-fold higher, respectively, than similar values estimated in humans treated with brimonidine tartrate ophthalmic solution 0.15%,1 drop in both eyes three

Canada - engelsk - Health Canada

lantheus mi canada inc - perflutren - suspension - 150mcl - perflutren 150mcl - other diagnostic agents

USA - engelsk - NLM (National Library of Medicine)

a-s medication solutions - .alpha.-tocopherol acetate, dl- (unii: wr1wpi7ew8) (.alpha.-tocopherol, dl- - unii:7qwa1rio01), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), cyanocobalamin (unii: p6yc3eg204) (cyanocobalamin - unii:p6yc3eg204), sodium fluoride (unii: 8zyq1474w7) (fluoride ion - unii:q80vpu408o), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), niacin (unii: 2679mf687a) (niacin - unii:2679mf687a), pyridoxine (unii: kv2jz1bi6z) (pyridoxine - unii:kv2jz1bi6z), riboflavin (unii: tlm297 - .alpha.-tocopherol, dl- 15 [iu] - off-white to pale yellow, speckled, fruit flavor, round-shaped chewable tablet debossed "sci" on one side and "3" on the other.

Canada - engelsk - Health Canada

janssen inc - levocabastine (levocabastine hydrochloride) - suspension - 0.05mg - levocabastine (levocabastine hydrochloride) 0.05mg - antiallergic agents

USA - engelsk - NLM (National Library of Medicine)

sancilio & company inc - .alpha.-tocopherol acetate, dl- (unii: wr1wpi7ew8) (.alpha.-tocopherol, dl- - unii:7qwa1rio01), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), cyanocobalamin (unii: p6yc3eg204) (cyanocobalamin - unii:p6yc3eg204), sodium fluoride (unii: 8zyq1474w7) (fluoride ion - unii:q80vpu408o), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), niacin (unii: 2679mf687a) (niacin - unii:2679mf687a), pyridoxine (unii: kv2jz1bi6z) (pyridoxine - unii:kv2jz1bi6z), riboflavin (unii: tlm297 - .alpha.-tocopherol, dl- 15 [iu] - off-white to pale yellow, speckled, fruit flavor, round-shaped chewable tablet debossed "sci" on one side and "5" on the other.